Swiss National Bank Grows Holdings in Henry Schein, Inc. (HSIC)
Swiss National Bank boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 101.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 739,518 shares of the company’s stock after purchasing an additional 373,259 shares during the quarter. Swiss National Bank owned approximately 467,723.74% of Henry Schein worth $60,633,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. YorkBridge Wealth Partners LLC boosted its holdings in shares of Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares during the period. Sun Life Financial INC boosted its holdings in shares of Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares during the period. Lee Financial Co acquired a new position in shares of Henry Schein during the second quarter valued at $161,000. Acrospire Investment Management LLC boosted its holdings in shares of Henry Schein by 150.0% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after acquiring an additional 600 shares during the period. Finally, HM Payson & Co. acquired a new position in shares of Henry Schein during the second quarter valued at $204,000. 53.07% of the stock is owned by hedge funds and other institutional investors.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.19% of the stock is currently owned by insiders.
Several brokerages have recently issued reports on HSIC. Royal Bank Of Canada reduced their price target on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a report on Tuesday, November 7th. Jefferies Group LLC restated a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research note on Friday, October 20th. Credit Suisse Group restated a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research note on Tuesday, August 29th. Leerink Swann restated a “market perform” rating and set a $77.00 price objective (down from $87.50) on shares of Henry Schein in a research note on Tuesday, November 7th. Finally, Morgan Stanley started coverage on shares of Henry Schein in a research note on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $89.88.
Shares of Henry Schein, Inc. (HSIC) opened at $67.05 on Monday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The stock has a market capitalization of $10,523.79, a PE ratio of 18.81, a price-to-earnings-growth ratio of 1.89 and a beta of 1.03. Henry Schein, Inc. has a twelve month low of $67.02 and a twelve month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. Henry Schein’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.84 EPS. equities analysts expect that Henry Schein, Inc. will post 3.6 earnings per share for the current year.
Henry Schein declared that its board has authorized a stock buyback plan on Monday, September 18th that allows the company to buyback $400.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.3% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: This report was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/11/13/swiss-national-bank-grows-holdings-in-henry-schein-inc-hsic.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.